{"id":397003,"date":"2021-12-18T09:34:33","date_gmt":"2021-12-18T12:34:33","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=397003"},"modified":"2021-12-18T09:34:33","modified_gmt":"2021-12-18T12:34:33","slug":"pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/","title":{"rendered":"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>New York.-<\/strong> <\/em>La farmac\u00e9utica Pfizer inform\u00f3 el viernes que cambi\u00f3 sus planes y que est\u00e1 probando tres dosis de su vacuna contra el coronavirus en beb\u00e9s y ni\u00f1os menores de 5 a\u00f1os, en lugar de las dos dosis usuales.<\/p>\n<p><!--more--><\/p>\n<p style=\"text-align: justify;\">La adici\u00f3n de la tercera dosis se decidi\u00f3 luego de que un an\u00e1lisis preliminar encontr\u00f3 que los ni\u00f1os de 2 a 4 a\u00f1os no tuvieron una respuesta inmunol\u00f3gica tan fuerte como se esperaba a las inyecciones especiales de dosis bajas.<\/p>\n<p style=\"text-align: justify;\">Pfizer hab\u00eda planeado publicar los datos de su estudio de ni\u00f1os menores de 5 a\u00f1os para el final del a\u00f1o. No est\u00e1 claro c\u00f3mo la nueva decisi\u00f3n demorar\u00e1 las gestiones para vacunar a los ni\u00f1os m\u00e1s peque\u00f1os.<\/p>\n<p style=\"text-align: justify;\">Pfizer y su socio BioNTech dijeron que, si el estudio con tres dosis es exitoso, planean solicitar la autorizaci\u00f3n de emergencia en alg\u00fan momento en 2022.<\/p>\n<p style=\"text-align: justify;\">Una versi\u00f3n de la vacuna de Pfizer ya est\u00e1 disponible para los ni\u00f1os de entre 5 y 11 a\u00f1os, con dosis que son la tercera parte de la provista a las personas de 12 a\u00f1os y mayores.<\/p>\n<p style=\"text-align: justify;\">Para los ni\u00f1os menores de 5 a\u00f1os, Pfizer est\u00e1 probando una dosis a\u00fan menor, de apenas 3 microgramos: una d\u00e9cima parte de la dosis para adultos.<\/p>\n<p style=\"text-align: justify;\">Los estudiosos analizaron por un mes a un grupo de ni\u00f1os en el estudio tras la segunda dosis, para determinar si los peque\u00f1os desarrollaban niveles de anticuerpos similares a los de los adolescentes y adultos que reciben las dosis regulares.<\/p>\n<p style=\"text-align: justify;\">Los menores de 2 a\u00f1os tuvieron niveles similares de anticuerpos, pero el nivel de respuesta inmunol\u00f3gica en los menores de entre 2 y 4 a\u00f1os fue menor, dijo Kathrin Jansen, la jefa de estudios de vacunas en Pfizer, durante una teleconferencia el viernes con inversionistas.<\/p>\n<p style=\"text-align: justify;\">Por ello el estudio est\u00e1 siendo expandido para evaluar tres inyecciones de esas dosis bajas en ni\u00f1os menores de 5 a\u00f1os. Esa tercera dosis ser\u00e1 aplicada al menos dos meses despu\u00e9s de la segunda.<\/p>\n<p style=\"text-align: justify;\">Las compa\u00f1\u00edas dijeron que en el estudio no se reportaron problemas relacionados con la inocuidad.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New York.- La farmac\u00e9utica Pfizer inform\u00f3 el viernes que cambi\u00f3 sus planes y que est\u00e1 probando tres dosis de su vacuna contra el coronavirus en beb\u00e9s y ni\u00f1os menores de 5 a\u00f1os, en lugar de las dos dosis usuales.<\/p>\n","protected":false},"author":2,"featured_media":395858,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[450,3425,3424],"class_list":{"0":"post-397003","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-internacionales","8":"tag-ninos","9":"tag-pfizer","10":"tag-vacunas"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"New York.- La farmac\u00e9utica Pfizer inform\u00f3 el viernes que cambi\u00f3 sus planes y que est\u00e1 probando tres dosis de su vacuna contra el coronavirus en beb\u00e9s y ni\u00f1os menores de 5 a\u00f1os, en lugar de las dos dosis usuales.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-18T12:34:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/Vacunas-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Roque Mereles\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Roque Mereles\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/\"},\"author\":{\"name\":\"Roque Mereles\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/7ec1ca00d0a9301ecc37fff902ff6741\"},\"headline\":\"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os\",\"datePublished\":\"2021-12-18T12:34:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/\"},\"wordCount\":374,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Vacunas-1.webp\",\"keywords\":[\"ni\u00f1os\",\"Pfizer\",\"Vacunas\"],\"articleSection\":[\"Internacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/\",\"name\":\"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Vacunas-1.webp\",\"datePublished\":\"2021-12-18T12:34:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Vacunas-1.webp\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Vacunas-1.webp\",\"width\":768,\"height\":512,\"caption\":\"La Vanguardia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/18\\\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/7ec1ca00d0a9301ecc37fff902ff6741\",\"name\":\"Roque Mereles\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/rmereles\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/","og_locale":"es_ES","og_type":"article","og_title":"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os - .::Agencia IP::.","og_description":"New York.- La farmac\u00e9utica Pfizer inform\u00f3 el viernes que cambi\u00f3 sus planes y que est\u00e1 probando tres dosis de su vacuna contra el coronavirus en beb\u00e9s y ni\u00f1os menores de 5 a\u00f1os, en lugar de las dos dosis usuales.","og_url":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2021-12-18T12:34:33+00:00","og_image":[{"width":768,"height":512,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/Vacunas-1.webp","type":"image\/webp"}],"author":"Roque Mereles","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Roque Mereles","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/"},"author":{"name":"Roque Mereles","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/7ec1ca00d0a9301ecc37fff902ff6741"},"headline":"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os","datePublished":"2021-12-18T12:34:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/"},"wordCount":374,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/Vacunas-1.webp","keywords":["ni\u00f1os","Pfizer","Vacunas"],"articleSection":["Internacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/","url":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/","name":"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/Vacunas-1.webp","datePublished":"2021-12-18T12:34:33+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/Vacunas-1.webp","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/Vacunas-1.webp","width":768,"height":512,"caption":"La Vanguardia"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/18\/pfizer-estudia-tercera-dosis-de-vacuna-en-menores-de-5-anos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Pfizer estudia tercera dosis de vacuna en menores de 5 a\u00f1os"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/7ec1ca00d0a9301ecc37fff902ff6741","name":"Roque Mereles","url":"https:\/\/www.ip.gov.py\/ip\/author\/rmereles\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/397003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=397003"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/397003\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/395858"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=397003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=397003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=397003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}